Formulation comprising GLP-1
US8492330B2 · kind B2 · utility
0Cited by
63References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2011 |
| Grant date | Jul 23, 2013 |
| Priority date | — |
| Expiry date | May 19, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.